Published Date: 08 Mar 2023
Researchers at the University of Queensland have adapted a test used around the world to screen people with dementia and Alzheimer's disease to make it suitable for people with hearing loss.
Read Full NewsNeuroblastoma is a type of cancer that affects the sympathetic nervous system in young children and is often difficult to treat, especially when the tumor cells carry multiple copies of the MYCN gene.
One in five women with breast or cervical cancer in low- and middle-income countries (LMICs) are diagnosed at an early stage, compared with more than one in three in high-income countries (HICs), new research suggests. For ...
1.
Rural residents continue to have higher odds of skin cancer, study finds
2.
FDA Authorizes Three Different Uses for Injectable Antibiotic.
3.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
4.
Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis
5.
Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival
1.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
2.
Genetic Screening: A Game Changer in Cancer Prevention
3.
Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy
4.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
5.
Boosting Checkpoint Immunotherapy in Hodgkin Lymphoma with JAK Inhibition: Advances & Insights
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
3.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC - Part III
5.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation